In 2012, the European Haemophilia Consortium (EHC) conducted a survey amongst its members on the state of haemophilia care in Europe. 35 countries responded on topics such as coagulation factor concentrate use, organisation of care, treatment regimens, access to specialist services, haemophilia replacement therapies and von Willebrand Disease (VWD) replacement therapies.
The full survey has been published in the scientific journal Haemophilia and can be accessed for a fee here. Please note that patients and their caregivers can get access the the content of the article at a reduced fee when using its content in relation to personal healthcare. Please check if terms and conditions for this use apply here.
Here you can consult a table summarising the results of the survey.